PrimeraDx (Primera Biosystems)
Providence
About PrimeraDx (Primera Biosystems)
PrimeraDx, Inc. offers multiplexed infectious disease assays. It provides Scalable Target Amplification Routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids. The company also offers ViraQuant, a multiplexed assay providing quantitative and simultaneous measurement of viruses; and FungiQuant Yeast and FungiQuant Mold, which are fungal panels for mycology testing. Its products are used in miRNA, DNA methylation, quantitative genotyping, gene expression, and viral load measurement applications. PrimeraDx, Inc. was founded in 2004 and is based in Mansfield, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $53.2M
- Funding stage: M&A
- Last round: Grant (Sep 2012)
- Website: primeradx.com
- Phone: 5083390452
Industries & Categories
Biopharma, Biotechnology, Chemical, Genetics
Social Profiles
Canonical: https://fsome.com/organization/primeradx-primera-biosystems-2426626 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.